Infants at Risk for Invasive Pneumococcal Disease in the 13-Valent Pneumococcal Conjugate Vaccine Era

Inci Yildirim^{1

2}, Stephen I Pelton^{3

4}

Affiliations

¹ Division of Pediatric Infectious Diseases, Emory University School of Medicine.
² Department of Epidemiology, Rollins School of Public Health, Atlanta, Georgia.
³ Schools of Medicine and Public Health, Boston University.
⁴ Division of Pediatric Infectious Diseases, Boston Medical Center, Massachusetts.

Editorial

Inci Yildirim et al. Clin Infect Dis. 2019.

. 2019 Jun 18;69(1):91-92.

doi: 10.1093/cid/ciy848.

Inci Yildirim^{1

2}, Stephen I Pelton^{3

4}

¹ Division of Pediatric Infectious Diseases, Emory University School of Medicine.
² Department of Epidemiology, Rollins School of Public Health, Atlanta, Georgia.
³ Schools of Medicine and Public Health, Boston University.
⁴ Division of Pediatric Infectious Diseases, Boston Medical Center, Massachusetts.

No abstract available

Keywords: conjugated vaccine; infants; invasive pneumococcal disease.

Comment on

Invasive Pneumococcal Disease in UK Children <1 Year of Age in the Post-13-Valent Pneumococcal Conjugate Vaccine Era: What Are the Risks Now?
Kent A, Makwana A, Sheppard CL, Collins S, Fry NK, Heath PT, Ramsay M, Ladhani SN. Kent A, et al. Clin Infect Dis. 2019 Jun 18;69(1):84-90. doi: 10.1093/cid/ciy842. Clin Infect Dis. 2019. PMID: 30281069